The U.S. Food and Drug Administration (FDA) has outlined its research priorities for tackling Highly Pathogenic Avian Influenza (HPAI) H5N1, which was first detected in U.S. dairy cattle in March 2024 and has since spread across several states. This novel occurrence of influenza in dairy cattle has prompted the FDA to focus on protecting both human and animal health.
In collaboration with federal and state partners, the FDA is conducting a detailed scientific analysis of commercial milk safety amid the ongoing HPAI H5N1 outbreak in North American dairy cattle. Early...